Head to head
Globus Medical vs Abbott Laboratories
Side-by-side on the measures that matter, with a plain-English read. Full detail: GMED · ABT
GMED
Globus Medical
73.75-3.51%
1-year price shape — +24% over the period
Quant Rating D · 64/100
vs
ABT
Abbott Laboratories
98.73+0.58%
1-year price shape — -24% over the period
Quant Rating E · 15/100
1-year performance, rebased to 100
Globus Medical edges it on the scoreable measures. Globus Medical has the highest Quant Rating (64); Globus Medical has done best over the past year (+24%); Globus Medical trades cheapest on trailing earnings.
| GMED | ABT | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Devices | Medical Devices |
| Last price | 73.75 | 98.73 |
| Change today | -3.51% | +0.58% |
| 1-year return | +24.3% | -24.1% |
| Market cap | $9.90B | $170.84B |
| 52-week range | 56.66 – 101.40 | 81.39 – 130.33 |
| Valuation | ||
| P/E (TTM) | 18.86 | 31.95 |
| P/E percentile, own 5-yr range | 6th | 62nd |
| P/B | 2.08 | 3.34 |
| Dividend yield | 0.00% | 2.47% |
| Profitability & growth | ||
| EPS (TTM) | 3.92 | 3.72 |
| Net profit (TTM) | $526.31M | $6.44B |
| Revenue (TTM) | $3.14B | $46.59B |
| Revenue growth (YoY) | +5.9% | +13.0% |
| Gross margin | 68.5% | 56.6% |
| Operating margin | 21.4% | 15.8% |
| Net margin | 17.0% | 11.6% |
| Free cash flow (TTM) | $745.84M | $7.82B |
| Ownership & sentiment | ||
| Institutional ownership | 90.2% | 81.2% |
| Insider activity (12mo) | 30 buy / 19 sell | 36 buy / 12 sell |
| Short interest (% of float) | 5.0% | 1.1% |
| Analyst consensus | 69% buy / 31% hold (13) | 100% buy (14) |
| Analyst price target | $99 (+34%) | $125 (+26%) |
| StockVane view | ||
| StockVane Quant Rating | D (64) | E (15) |
| Company | ||
| Employees | 6,000 | 115,000 |
| Founded | 2003 | 1888 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.